Federated Hermes
CAI

Federated Hermes’s Caris Life Sciences CAI Stock Holding History

Federated Hermes’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.09M Buy
285,598
+46,448
+19% +$831K 0.01% 839
2026
Q1 		$4.28M Buy
239,150
+236,150
+7,872% +$5.16M 0.01% 827
2025
Q4 		$80.9K Buy
+3,000
New +$84.5K ﹤0.01% 1595
2025
Q3 		– Sell
-14,200
Closed -$379K – 2267
2025
Q2 		$379K Buy
+14,200
New +$383K ﹤0.01% 1397

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Federated Hermes's CAI Position: Q2 2026 in Review

Federated Hermes increased its Caris Life Sciences (CAI) stake by 19% in Q2 2026, buying an estimated $831K and bringing the position to 285,598 shares worth $5.09M. The position accounts for 0.01% of the portfolio, ranked #839.

Federated Hermes first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Federated Hermes held 285,598 shares of Caris Life Sciences worth $5.09M as of Q2 2026.
  • Federated Hermes bought 46,448 Caris Life Sciences shares in Q2 2026, an estimated $831K.
  • Caris Life Sciences made up 0.01% of Federated Hermes's portfolio in Q2 2026, its #839 holding.
  • Federated Hermes first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.